TUESDAY, June 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid. The approval is based […]
The post FDA Approves Dupixent for Bullous Pemphigoid first appeared on Blackandmed .
